IDH3A and central nervous system cancer: These studies showed that in glioma, CASCADES is highly expressed in both primary and recurrent gliomas with wild‐type isocitrate dehydrogenase (IDH); conversely, we found no significant evidence of expression of CASCADES in IDH‐mutant gliomas, regardless of 1p and 19q deletion status (Fig. 2E).